All Stories

  1. Selenium: A Trace Element for a Healthy Skeleton - A Narrative Review

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, June 2020, Bentham Science Publishers

    Dr. ALBERTO FALCHETTI

  2. DIAGNOSIS OF ENDOCRINE DISEASE: Evaluation of bone fragility in endocrine disorders

    Article • European Journal of Endocrinology, June 2019, Bioscientifica

    Dr. ALBERTO FALCHETTI

  3. Cortisol secretion, sensitivity, and activity are associated with hypertension in postmenopausal eucortisolemic women

    Article • The Journal of Clinical Endocrinology & Metabolism, May 2019, Endocrine Society

    Dr. ALBERTO FALCHETTI

  4. Hypovitaminosis D: Is It Time to Consider the Use of Calcifediol?

    Article • Nutrients, May 2019, MDPI AG

    Dr. ALBERTO FALCHETTI

  5. Efficacy and safety of abaloparatide for the treatment of post-menopausal osteoporosis

    Article • Expert Opinion on Pharmacotherapy, March 2019, Taylor & Francis

    Dr. ALBERTO FALCHETTI

  6. Paget’s Disease of Bone

    Article • Calcified Tissue International, January 2019, Springer Science + Business Media

    Dr. ALBERTO FALCHETTI

  7. A rare syndrome of bone fibrous dysplasia associated with intramuscular myxomas.

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, December 2018, Bentham Science Publishers

    Dr. ALBERTO FALCHETTI, VINCENZO TRIGGIANI, veronica tonelli

  8. Multiple Endocrine Neoplasia type 1 Syndrome and GEP-tumors. Gentoype-phenotype correlation

    Article • HORMONES, August 2018, Springer Science + Business Media

    Dr. ALBERTO FALCHETTI

  9. vitamin C roles in osteoporosis and fracture prevention.

    Article • Expert Review of Precision Medicine and Drug Development, May 2018, Taylor & Francis

    Dr. ALBERTO FALCHETTI

  10. Italian Association of Clinical Endocrinologists (AME) and Italian Chapter of the American Association of Clinical Endocrinologists (AACE) Position Statement: Clinical Management of Vitamin D Deficiency in Adults

    Article • Nutrients, April 2018, MDPI AG

    Dr. ALBERTO FALCHETTI

  11. Evaluation of the effect of denosumab, , in primary hyperparathyroidism-related osteoporosis.

    Article • Journal of the American Geriatrics Society, January 2018, Wiley

    iacopo chiodini, Dr. ALBERTO FALCHETTI

  12. Mitochondriopathies and bone health

    Article • Trends in Biomedical Research, January 2018, Open Access Text Pvt, Ltd.

    Dr. ALBERTO FALCHETTI

  13. New approaches in genetic diagnosis of cancer prone syndromes

    Article • F1000Research, January 2017, Faculty of 1000, Ltd.

    Dr. ALBERTO FALCHETTI

  14. Faculty of 1000 evaluation for Complementary activities of DOT1L and Menin inhibitors in MLL-rearranged leukemia.

    Article • January 2017, Faculty of 1000, Ltd.

    Dr. ALBERTO FALCHETTI

  15. Faculty of 1000 evaluation for Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4).

    Article • January 2017, Faculty of 1000, Ltd.

    Dr. ALBERTO FALCHETTI

  16. Faculty of 1000 evaluation for Next generation sequencing in endocrine practice.

    Article • January 2017, Faculty of 1000, Ltd.

    Dr. ALBERTO FALCHETTI

  17. Faculty of 1000 evaluation for Association between the p27 rs2066827 variant and tumor multiplicity in patients harboring MEN1 germline mutations.

    Article • January 2017, Faculty of 1000, Ltd.

    Dr. ALBERTO FALCHETTI

  18. Faculty of 1000 evaluation for De novo mutation in MEN1 is not associated with parental somatic mosaicism.

    Article • January 2017, Faculty of 1000, Ltd.

    Dr. ALBERTO FALCHETTI

  19. Faculty of 1000 evaluation for DIAGNOSIS OF ENDOCRINE DISEASE: High-yield thyroid fine-needle aspiration cytology: an update focused on ancillary techniques improving its accuracy.

    Article • January 2017, Faculty of 1000, Ltd.

    Dr. ALBERTO FALCHETTI

  20. Faculty of 1000 evaluation for Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1.

    Article • January 2017, Faculty of 1000, Ltd.

    Dr. ALBERTO FALCHETTI

  21. Faculty of 1000 evaluation for Genetic test in multiple endocrine neoplasia type 1 syndrome: An evolving story.

    Article • January 2017, Faculty of 1000, Ltd.

    Dr. ALBERTO FALCHETTI

  22. Faculty of 1000 evaluation for Next-Generation Sequencing Approaches in Cancer: Where Have They Brought Us and Where Will They Take Us?

    Article • January 2017, Faculty of 1000, Ltd.

    Dr. ALBERTO FALCHETTI

  23. Faculty of 1000 evaluation for New insights into the generation and role of de novo mutations in health and disease.

    Article • January 2017, Faculty of 1000, Ltd.

    Dr. ALBERTO FALCHETTI

  24. vitamin K and bone health

    Article • Expert Review of Precision Medicine and Drug Development, April 2016, Taylor & Francis

    Dr. ALBERTO FALCHETTI

  25. vitamin D metabolites, bone health, bone cells, bone pathophysiology and fracture risk

    Article • Food and Nutrition Sciences, January 2016, Scientific Research Publishing, Inc,

    Dr. ALBERTO FALCHETTI

  26. The Regulatory Network Menin-MicroRNA 26a As a Possible Target for RNA-Based Therapy of Bone Diseases

    Article • Nucleic Acid Therapeutics, April 2012, Mary Ann Liebert Inc

    Dr. ALBERTO FALCHETTI

  27. A novel germline inactivating mutation in the CASR gene in an Italian kindred affected by familial hypocalciuric hypercalcemia

    Article • February 2012, Bioscientifica

    Dr. ALBERTO FALCHETTI, Prof Giuseppe Vezzoli

  28. Genetic Aspects of Hereditary Hyperparathyroidism

    Article • December 2011, Springer Science + Business Media

    Dr. ALBERTO FALCHETTI

  29. Molecular diagnosis of parathyroid carcinoma: a reality in the near future

    Article • Expert Opinion on Medical Diagnostics, November 2011, Informa Healthcare

    Dr. ALBERTO FALCHETTI

  30. Genome-wide association identifies three new susceptibility loci for Paget's disease of bone

    Article • Nature Genetics, May 2011, Nature

    Dr. ALBERTO FALCHETTI

  31. Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes

    Article • European Journal of Endocrinology, November 2010, Bioscientifica

    Dr. ALBERTO FALCHETTI

  32. Corrigendum

    Article • European Journal of Clinical Investigation, September 2010, Wiley

    Dr. ALBERTO FALCHETTI

  33. Ribozyme-mediated compensatory induction of menin-oncosuppressor function in primary fibroblasts from MEN1 patients

    Article • Cancer Gene Therapy, August 2010, Nature

    Dr. ALBERTO FALCHETTI

  34. LRP5 gene polymorphism and cortical bone

    Article • Aging Clinical and Experimental Research, August 2010, Springer Science + Business Media

    Dr. ALBERTO FALCHETTI

  35. Pagetʼs disease of bone: thereʼs more than the affected skeletal – a clinical review and suggestions for the clinical practice

    Article • Current Opinion in Rheumatology, July 2010, Wolters Kluwer Health

    Dr. ALBERTO FALCHETTI

  36. Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes

    Article • European Journal of Endocrinology, June 2010, Bioscientifica

    Dr. ALBERTO FALCHETTI

  37. Genetic aspects of the Paget’s disease of bone: concerns on the introduction of DNA-based tests in the clinical practice. Advantages and disadvantages of its application

    Article • European Journal of Clinical Investigation, May 2010, Wiley

    Dr. ALBERTO FALCHETTI

  38. Genetic screening for multiple endocrine neoplasia syndrome type 1 (MEN-1): when and how

    Article • F1000 Medicine Reports, February 2010, Faculty of 1000, Ltd.

    Dr. ALBERTO FALCHETTI

  39. Thyroid Cancer: Current Molecular Perspectives

    Article • Journal of Oncology, January 2010, Hindawi Publishing Corporation

    Dr. ALBERTO FALCHETTI

  40. Multiple endocrine neoplasia type 1 (MEN1): Not only inherited endocrine tumors

    Article • Genetics in Medicine, November 2009, Nature

    Dr. ALBERTO FALCHETTI

  41. Germline mutations in MEN1 and BRCA1 genes in a woman with familial multiple endocrine neoplasia type 1 and inherited breast–ovarian cancer syndromes: a case report

    Article • Cancer Genetics and Cytogenetics, November 2009, Elsevier

    Dr. ALBERTO FALCHETTI

  42. Infiltrating giant cell tumor in a case of Paget’s disease of bone

    Article • Archives of Osteoporosis, August 2009, Springer Science + Business Media

    Dr. ALBERTO FALCHETTI

  43. DNA-based test: when and why to apply it to primary hyperparathyroidism clinical phenotypes

    Article • Journal of Internal Medicine, July 2009, Wiley

    Dr. ALBERTO FALCHETTI

  44. A Novel Recessive Mutation of Fibroblast Growth Factor-23 in Tumoral Calcinosis

    Article • Journal of Bone and Joint Surgery, May 2009, The Journal of Bone and Joint Surgery, Inc.

    Dr. ALBERTO FALCHETTI

  45. Multiple Endocrine Neoplasia Type I Variants and Phenocopies: More than a Nosological Issue?

    Article • The Journal of Clinical Endocrinology & Metabolism, May 2009, Endocrine Society

    Dr. ALBERTO FALCHETTI

  46. Characterization of a Non-UBA Domain Missense Mutation of Sequestosome 1 (SQSTM1) in Paget's Disease of Bone

    Article • Journal of Bone and Mineral Research, April 2009, Wiley

    Dr. ALBERTO FALCHETTI

  47. Faculty of 1000 evaluation for Menin interacts with IQGAP1 to enhance intercellular adhesion of beta-cells.

    Article • January 2009, Faculty of 1000, Ltd.

    Dr. ALBERTO FALCHETTI

  48. Surgical Approach in Hereditary Hyperparathyroidism

    Article • Endocrine Journal, January 2009, Japan Endocrine Society

    Dr. ALBERTO FALCHETTI

  49. Genetica dell’osteoporosi, dell’osteopetrosi e dell’osteogenesi imperfetta

    Article • January 2009, Springer Science + Business Media

    Dr. ALBERTO FALCHETTI

  50. Genetic Epidemiology of Paget’s Disease of Bone in Italy: sequestosome1/p62 Gene Mutational Test and Haplotype Analysis at 5q35 in a Large Representative Series of Sporadic and Familial Italian Cases of Paget’s Disease of Bone

    Article • Calcified Tissue International, December 2008, Springer Science + Business Media

    Dr. ALBERTO FALCHETTI

  51. Erratum to “ Multiple endocrine neoplasms” [Best Practice & Research Clinical Rheumatology 2008; 22: 149–163]

    Article • Best Practice & Research Clinical Rheumatology, December 2008, Elsevier

    Dr. ALBERTO FALCHETTI

  52. The genetic ascertainment of multiple endocrine neoplasia type 1 syndrome by ancient DNA analysis

    Article • Journal of Endocrinological Investigation, October 2008, Springer Science + Business Media

    Dr. ALBERTO FALCHETTI

  53. Modulatory effect of farnesyl pyrophosphate synthase (FDPS)rs2297480polymorphism on the response to long-term amino-bisphosphonate treatment in postmenopausal osteoporosis

    Article • Current Medical Research and Opinion, August 2008, Informa Healthcare

    Dr. ALBERTO FALCHETTI

  54. A patient with MEN1-associated hyperparathyroidism, responsive to cinacalcet

    Article • Nature Clinical Practice Endocrinology &#38 Metabolism, July 2008, Nature

    Dr. ALBERTO FALCHETTI

  55. Large-scale analysis of association between polymorphisms in the transforming growth factor beta 1 gene (TGFB1) and osteoporosis: The GENOMOS study

    Article • Bone, May 2008, Elsevier

    Dr. ALBERTO FALCHETTI, Daniel Grinberg

  56. A patient with MEN1-associated hyperparathyroidism, responsive to cinacalcet

    Article • Nature Clinical Practice Endocrinology &#38 Metabolism, April 2008, Nature

    Dr. ALBERTO FALCHETTI

  57. Silent Familial Isolated Pituitary Adenomas: Histopathological and Clinical Case Report

    Article • Endocrine Pathology, March 2008, Springer Science + Business Media

    Dr. ALBERTO FALCHETTI

  58. Multiple endocrine neoplasms

    Article • Best Practice & Research Clinical Rheumatology, March 2008, Elsevier

    Dr. ALBERTO FALCHETTI

  59. Multiple Endocrine Neoplasia Type 1

    Article • January 2008, Elsevier

    Dr. ALBERTO FALCHETTI

  60. Is Total Parathyroidectomy the Treatment of Choice for Hyperparathyroidism in Multiple Endocrine Neoplasia Type 1?

    Article • Annals of Surgery, December 2007, Wolters Kluwer Health

    Dr. ALBERTO FALCHETTI

  61. Relationship of Volumetric Bone Mineral Density and Structural Parameters with ERα Gene Polymorphisms

    Article • Calcified Tissue International, May 2007, Springer Science + Business Media

    Dr. ALBERTO FALCHETTI

  62. Gastrinoma (Duodenal and Pancreatic)

    Article • Neuroendocrinology, February 2007, Karger Publishers

    Dr. ALBERTO FALCHETTI, MD, PhD José Manuel Lopes

  63. Poorly Differentiated Carcinomas of the Foregut (Gastric, Duodenal and Pancreatic)

    Article • Neuroendocrinology, February 2007, Karger Publishers

    Dr. ALBERTO FALCHETTI, MD, PhD José Manuel Lopes

  64. Rare Functioning Pancreatic Endocrine Tumors

    Article • Neuroendocrinology, February 2007, Karger Publishers

    Dr. ALBERTO FALCHETTI, MD, PhD José Manuel Lopes

  65. Well-Differentiated Duodenal Tumor/Carcinoma (Excluding Gastrinomas)

    Article • Neuroendocrinology, February 2007, Karger Publishers

    Dr. ALBERTO FALCHETTI, MD, PhD José Manuel Lopes

  66. Well-Differentiated Gastric Tumors/Carcinomas

    Article • Neuroendocrinology, February 2007, Karger Publishers

    Dr. ALBERTO FALCHETTI, MD, PhD José Manuel Lopes

  67. Well-Differentiated Pancreatic Tumor/Carcinoma: Insulinoma

    Article • Neuroendocrinology, February 2007, Karger Publishers

    Dr. ALBERTO FALCHETTI, MD, PhD José Manuel Lopes

  68. FokI Polymorphism of the Vitamin D Receptor Gene Correlates with Parameters of Bone Mass and Turnover in a Female Population of the Italian Island of Lampedusa

    Article • Calcified Tissue International, December 2006, Springer Science + Business Media

    Dr. ALBERTO FALCHETTI

  69. What Is the Relationship Between Paget's Disease of Bone and Hyperparathyroidism?

    Article • Journal of Bone and Mineral Research, December 2006, Wiley

    Dr. ALBERTO FALCHETTI

  70. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system

    Article • Virchows Archiv, September 2006, Springer Science + Business Media

    Dr. ALBERTO FALCHETTI, MD, PhD José Manuel Lopes

  71. Pancreatectomy in Multiple Endocrine Neoplasia Type 1-Related Gastrinomas and Pancreatic Endocrine Neoplasias

    Article • Annals of Surgery, July 2006, Wolters Kluwer Health

    Dr. ALBERTO FALCHETTI

  72. Correction: Large-Scale Evidence for the Effect of the COLIA1 Sp1 Polymorphism on Osteoporosis Outcomes: The GENOMOS Study

    Article • PLoS Medicine, May 2006, PLOS

    Dr. ALBERTO FALCHETTI

  73. MEN1 family with a novel frameshift mutation

    Article • Journal of Endocrinological Investigation, May 2006, Springer Science + Business Media

    Dr. ALBERTO FALCHETTI

  74. Large-Scale Evidence for the Effect of the COLIA1 Sp1 Polymorphism on Osteoporosis Outcomes: The GENOMOS Study

    Article • PLoS Medicine, February 2006, PLOS

    Dr. ALBERTO FALCHETTI

  75. Well-Differentiated Pancreatic Nonfunctioning Tumors/Carcinoma

    Article • Neuroendocrinology, January 2006, Karger Publishers

    Dr. ALBERTO FALCHETTI, MD, PhD José Manuel Lopes

  76. Article • Orphanet Journal of Rare Diseases, January 2006, Springer Science + Business Media

    Dr. ALBERTO FALCHETTI

  77. Article • Orphanet Journal of Rare Diseases, January 2006, Springer Science + Business Media

    Dr. ALBERTO FALCHETTI

  78. ER  is a potent inhibitor of cell proliferation in the HCT8 human colon cancer cell line through regulation of cell cycle components

    Article • Endocrine Related Cancer, June 2005, Bioscientifica

    Dr. ALBERTO FALCHETTI

  79. Lessons from genes mutated in multiple endocrine neoplasia (MEN) syndromes

    Article • Annales d Endocrinologie, June 2005, Elsevier

    Dr. ALBERTO FALCHETTI

  80. Thymic Neuroendocrine Carcinoma (Carcinoid) in Multiple Endocrine Neoplasia Type 1 Syndrome: The Italian Series

    Article • The Journal of Clinical Endocrinology & Metabolism, May 2005, Endocrine Society

    Dr. ALBERTO FALCHETTI

  81. Surgery for gastroenteropancreatic tumours in multiple endocrine neoplasia type 1: review and personal experience

    Article • Journal of Internal Medicine, January 2005, Wiley

    Dr. ALBERTO FALCHETTI

  82. Multiple Endocrine Neoplasias: Types 1 and 2

    Article • December 2004, Taylor & Francis

    Dr. ALBERTO FALCHETTI

  83. Azidothymidine Induces Apoptosis and Inhibits Cell Growth and Telomerase Activity of Human Parathyroid Cancer Cells in Culture

    Article • Journal of Bone and Mineral Research, November 2004, Wiley

    Dr. ALBERTO FALCHETTI

  84. Calcium Bioavailability From a Calcium-Rich Mineral Water, With Some Observations on Method

    Article • Journal of Clinical Gastroenterology, October 2004, Wolters Kluwer Health

    Dr. ALBERTO FALCHETTI

  85. A PolymorphicCYP19TTTA Repeat Influences Aromatase Activity and Estrogen Levels in Elderly Men: Effects on Bone Metabolism

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2004, Endocrine Society

    Dr. ALBERTO FALCHETTI

  86. Calcium agonists in hyperparathyroidism

    Article • Expert Opinion on Investigational Drugs, March 2004, Informa Healthcare

    Dr. ALBERTO FALCHETTI

  87. Two Novel Mutations at Exon 8 of the Sequestosome 1 (SQSTM1) Gene in an Italian Series of Patients Affected by Paget's Disease of Bone (PDB)

    Article • Journal of Bone and Mineral Research, February 2004, Wiley

    Dr. ALBERTO FALCHETTI

  88. Genetics of Primary Hyperparathyroidism

    Article • Urologia Internationalis, January 2004, Karger Publishers

    Dr. ALBERTO FALCHETTI

  89. Calcium agonists in hyperparathyroidism

    Article • Expert Opinion on Investigational Drugs, January 2004, Informa Healthcare

    Dr. ALBERTO FALCHETTI

  90. Calcium disorders and bone diseases

    Article • November 2002, Taylor & Francis

    Dr. ALBERTO FALCHETTI

  91. Influence of Calcium-Sensing Receptor Gene on Urinary Calcium Excretion in Stone-Forming Patients

    Article • Journal of the American Society of Nephrology, October 2002, American Society of Nephrology

    Dr. ALBERTO FALCHETTI, Prof Giuseppe Vezzoli

  92. Genetics of osteoporosis: role of steroid hormone receptor gene polymorphisms

    Article • The Journal of Steroid Biochemistry and Molecular Biology, May 2002, Elsevier

    Dr. ALBERTO FALCHETTI

  93. Multiple Endocrine Neoplasia Type 1

    Article • January 2002, Elsevier

    Dr. ALBERTO FALCHETTI

  94. Genetics of Osteoporosis

    Article • January 2002, Springer Science + Business Media

    Dr. ALBERTO FALCHETTI

  95. Multiple Endocrine Neoplasia Type 1

    Article • January 2002, Elsevier

    Dr. ALBERTO FALCHETTI

  96. Article • Arthritis Research, January 2002, Springer Science + Business Media

    Dr. ALBERTO FALCHETTI

  97. CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2

    Article • The Journal of Clinical Endocrinology & Metabolism, December 2001, Endocrine Society

    Dr. ALBERTO FALCHETTI

  98. Polymorphism of the Aromatase Gene in Postmenopausal Italian Women: Distribution and Correlation with Bone Mass and Fracture Risk1

    Article • The Journal of Clinical Endocrinology & Metabolism, May 2001, Endocrine Society

    Dr. ALBERTO FALCHETTI

  99. Polymorphism of the Aromatase Gene in Postmenopausal Italian Women: Distribution and Correlation with Bone Mass and Fracture Risk

    Article • The Journal of Clinical Endocrinology & Metabolism, May 2001, Endocrine Society

    Dr. ALBERTO FALCHETTI

  100. Microencapsulation of Human Parathyroid Cells: An “in Vitro” Study

    Article • Journal of Surgical Research, March 2001, Elsevier

    Dr. ALBERTO FALCHETTI

  101. Article • Arthritis Research, January 2001, Springer Science + Business Media

    Dr. ALBERTO FALCHETTI

  102. Somatic Mutation Analysis of the MEN1 Gene in Adrenocortical Tumors Using Denaturing Gradient Gel Electrophoresis (DGGE)

    Article • International Journal on Disability and Human Development, January 2001, De Gruyter

    Dr. ALBERTO FALCHETTI

  103. MEN1 gene mutation analysis in Italian patients with multiple endocrine neoplasia type 1

    Article • European Journal of Endocrinology, February 2000, Bioscientifica

    Dr. ALBERTO FALCHETTI

  104. Telomerase Repeat Amplification Protocol (TRAP): A New Molecular Marker for Parathyroid Carcinoma

    Article • Biochemical and Biophysical Research Communications, November 1999, Elsevier

    Dr. ALBERTO FALCHETTI

  105. FokI Polymorphism at Translation Initiation Site of the Vitamin D Receptor Gene Predicts Bone Mineral Density and Vertebral Fractures in Postmenopausal Italian Women

    Article • Journal of Bone and Mineral Research, August 1999, Wiley

    Dr. ALBERTO FALCHETTI

  106. Polymorphisms of the Calcitonin Receptor Gene Are Associated with Bone Mineral Density in Postmenopausal Italian Women

    Article • Biochemical and Biophysical Research Communications, July 1998, Elsevier

    Dr. ALBERTO FALCHETTI

  107. Allelic Variants of Human Calcitonin Receptor: Distribution and Association with Bone Mass in Postmenopausal Italian Women

    Article • Biochemical and Biophysical Research Communications, April 1998, Elsevier

    Dr. ALBERTO FALCHETTI

  108. Genetic testing for multiple endocrine neoplasias

    Article • Endocrine Related Cancer, March 1998, Bioscientifica

    Dr. ALBERTO FALCHETTI

  109. Aggressive Forms of Gastric Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type I

    Article • The American Journal of Surgical Pathology, September 1997, Wolters Kluwer Health

    Dr. ALBERTO FALCHETTI

  110. Allelic Loss in Parathyroid Tumors from Individuals Homozygous for Multiple Endocrine Neoplasia Type 11

    Article • The Journal of Clinical Endocrinology & Metabolism, July 1997, Endocrine Society

    Dr. ALBERTO FALCHETTI

  111. Allelic Loss in Parathyroid Tumors from Individuals Homozygous for Multiple Endocrine Neoplasia Type 1

    Article • The Journal of Clinical Endocrinology & Metabolism, July 1997, Endocrine Society

    Dr. ALBERTO FALCHETTI

  112. HPE Cells: A Clonal Endothelial Cell Line Established From Human Parathyroid Tissue (Human Parathyroid Cell Line)

    Article • Endothelium, January 1997, Taylor & Francis

    Dr. ALBERTO FALCHETTI

  113. Clonal Analysis by Chromosome 11 Microsatellite-PCR of Microdissected Parathyroid Tumors from MEN 1 Patients

    Article • Biochemical and Biophysical Research Communications, October 1996, Elsevier

    Dr. ALBERTO FALCHETTI

  114. Are allelic losses at 11q13 universal in MEN 1 tumors?

    Article • The Journal of Clinical Endocrinology & Metabolism, September 1996, Endocrine Society

    Dr. ALBERTO FALCHETTI

  115. Steroid 5α-reductase 2 deficiency: virilization in early infancy may be due to partial function of mutant enzyme

    Article • Clinical Endocrinology, April 1996, Wiley

    Dr. ALBERTO FALCHETTI

  116. Characterization and function of the receptor for IGF-I in human preosteoclastic cells

    Article • Bone, March 1996, Elsevier

    Dr. ALBERTO FALCHETTI

  117. Evidence for Bioeffects of LY 139478 on the Human Preosteoclastic Cell Line FLG 29.1

    Article • Biochemical and Biophysical Research Communications, June 1995, Elsevier

    Dr. ALBERTO FALCHETTI

  118. Genetic screening to identify the gene carrier in Italian and German kindreds affected by multiple endocrine neoplasia type 1 (MEN 1) syndrome

    Article • Journal of Endocrinological Investigation, May 1995, Springer Science + Business Media

    Dr. ALBERTO FALCHETTI

  119. Lack of allelic loss at the multiple endocrine neoplasia type 1(MEN-1) gene locus in a pancreatic ductal (non-endocrine) adenocarcinoma of a patient with the MEN-1 syndrome

    Article • Virchows Archiv, March 1995, Springer Science + Business Media

    Dr. ALBERTO FALCHETTI

  120. RFLP Analysis of Human Chromosome 11 Region q13 in Multiple Symmetrical Lipomatosis and Multiple Endocrine Neoplasia Type 1-Associated Lipomas

    Article • Biochemical and Biophysical Research Communications, February 1995, Elsevier

    Dr. ALBERTO FALCHETTI

  121. Relaxin influences growth, differentiation and cell-cell adhesion of human breast-cancer cells in culture

    Article • International Journal of Cancer, April 1994, Wiley

    Dr. ALBERTO FALCHETTI, Daniele Bani

  122. Production of basic fibroblast growth factor by gastric carcinoid tumors and their putative cells of origin

    Article • Human Pathology, February 1994, Elsevier

    Dr. ALBERTO FALCHETTI

  123. Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11

    Article • The Journal of Clinical Endocrinology & Metabolism, January 1993, Endocrine Society

    Dr. ALBERTO FALCHETTI

  124. Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11.

    Article • The Journal of Clinical Endocrinology & Metabolism, January 1993, Endocrine Society

    Dr. ALBERTO FALCHETTI

  125. Clonality of Parathyroid Tumors in Familial Multiple Endocrine Neoplasia Type 1

    Article • New England Journal of Medicine, July 1989, New England Journal of Medicine (NEJM/MMS)

    Dr. ALBERTO FALCHETTI

  126. Genetics of Osteoporosis

    Article • Springer Science + Business Media

    Dr. ALBERTO FALCHETTI

  127. Faculty of 1000 evaluation for Menin controls growth of pancreatic beta-cells in pregnant mice and promotes gestational diabetes mellitus.

    Article • Faculty of 1000, Ltd.

    Dr. ALBERTO FALCHETTI

  128. Faculty of 1000 evaluation for Global expression profiling of murine MEN1-associated tumors reveals a regulatory role for menin in transcription, cell cycle and chromatin remodelling.

    Article • Faculty of 1000, Ltd.

    Dr. ALBERTO FALCHETTI

  129. Faculty of 1000 evaluation for Care for patients with multiple endocrine neoplasia type 1: the current evidence base.

    Article • Faculty of 1000, Ltd.

    Dr. ALBERTO FALCHETTI

  130. Faculty of 1000 evaluation for Screening of patients with multiple endocrine neoplasia type 1 (MEN-1): a critical analysis of its value.

    Article • Faculty of 1000, Ltd.

    Dr. ALBERTO FALCHETTI

  131. Faculty of 1000 evaluation for A nonsynonymous TNFRSF11A variation increases NFκB activity and the severity of Paget's disease.

    Article • Faculty of 1000, Ltd.

    Dr. ALBERTO FALCHETTI

  132. Faculty of 1000 evaluation for Asymptomatic children with multiple endocrine neoplasia type 1 mutations may harbor nonfunctioning pancreatic neuroendocrine tumors.

    Article • Faculty of 1000, Ltd.

    Dr. ALBERTO FALCHETTI

  133. Faculty of 1000 evaluation for Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers.

    Article • Faculty of 1000, Ltd.

    Dr. ALBERTO FALCHETTI

  134. Faculty of 1000 evaluation for Primary lymph node gastrinoma or occult duodenal microgastrinoma with lymph node metastases in a MEN1 patient: the need for a systematic search for the primary tumor.

    Article • Faculty of 1000, Ltd.

    Dr. ALBERTO FALCHETTI

  135. Faculty of 1000 evaluation for Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN1 from the GTE (Groupe des Tumeurs Endocrines).

    Article • Faculty of 1000, Ltd.

    Dr. ALBERTO FALCHETTI

  136. Faculty of 1000 evaluation for Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.

    Article • Faculty of 1000, Ltd.

    Dr. ALBERTO FALCHETTI